{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:24Z","timestamp":1792782864581,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Saint Joseph Saint Luc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-024-02323-z","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T07:28:54Z","timestamp":1719386934000},"page":"1537-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Continuous glucose monitoring with FreeStyle Libre PRO sensor in patients with type 2 diabetes and end-stage renal failure on haemoDIALysis (FSLPRO-DIAL pilot study)"],"prefix":"10.1007","volume":"61","author":[{"given":"Zo\u00e9","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Belloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Prunescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Doroszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Luyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-5002","authenticated-orcid":false,"given":"Lucien","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"2323_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"Ahmad E, Lim S, Lamptey R et al (2022) Type 2 diabetes. Lancet 400:1803\u20131820. https:\/\/doi.org\/10.1016\/S0140-6736(22)01655-5","journal-title":"Lancet"},{"key":"2323_CR2","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS et al (2022) Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabet Care 45:2753\u20132786. https:\/\/doi.org\/10.2337\/dci22-0034","journal-title":"Diabet Care"},{"key":"2323_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2215\/CJN.04510422","volume":"18","author":"RJ Galindo","year":"2023","unstructured":"Galindo RJ, de Boer IH, Neumiller JJ, Tuttle KR (2023) Continuous glucose monitoring to optimize management of diabetes in patients with advanced CKD. Clin J Am Soc Nephrol 18:130. https:\/\/doi.org\/10.2215\/CJN.04510422","journal-title":"Clin J Am Soc Nephrol"},{"key":"2323_CR4","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL et al (2018) Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabet Care 41:2275\u20132280. https:\/\/doi.org\/10.2337\/dc18-1581","journal-title":"Diabet Care"},{"key":"2323_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabet Care 42:1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabet Care"},{"key":"2323_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2337\/dc08-1688","volume":"32","author":"S Kazempour-Ardebili","year":"2009","unstructured":"Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T et al (2009) Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabet Care 32:1137\u20131142. https:\/\/doi.org\/10.2337\/dc08-1688","journal-title":"Diabet Care"},{"key":"2323_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/dme.12294","volume":"30","author":"L Meyer","year":"2013","unstructured":"Meyer L, Chantrel F, Imhoff O et al (2013) Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis. Diabet Med 30:1388\u20131389. https:\/\/doi.org\/10.1111\/dme.12294","journal-title":"Diabet Med"},{"key":"2323_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5414\/CN108280","volume":"82","author":"L K\u00e9p\u00e9n\u00e9kian","year":"2014","unstructured":"K\u00e9p\u00e9n\u00e9kian L, Smagala A, Meyer L et al (2014) Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study. Clin Neurol 82:240\u2013246. https:\/\/doi.org\/10.5414\/CN108280","journal-title":"Clin Neurol"},{"key":"2323_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","volume":"107","author":"M Joubert","year":"2015","unstructured":"Joubert M, Fourmy C, Henri P et al (2015) Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study. Diabet Res Clin Pract 107:348\u2013354. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.026","journal-title":"Diabet Res Clin Pract"},{"key":"2323_CR10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.2337\/dc22-0073","volume":"45","author":"O Villard","year":"2022","unstructured":"Villard O, Breton MD, Rao S et al (2022) Accuracy of a factory-calibrated continuous glucose monitor in individuals with diabetes on hemodialysis. Diabet Care 45:1666\u20131669. https:\/\/doi.org\/10.2337\/dc22-0073","journal-title":"Diabet Care"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/19322968231173447","volume":"17","author":"C Horne","year":"2023","unstructured":"Horne C, Cranston I, Amos M, Flowers K (2023) Accuracy of continuous glucose monitoring in an insulin-treated population requiring haemodialysis. J Diabet Sci Technol 17:971\u2013975. https:\/\/doi.org\/10.1177\/19322968231173447","journal-title":"J Diabet Sci Technol"},{"key":"2323_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2337\/dc23-1276","volume":"47","author":"CY Kaminski","year":"2023","unstructured":"Kaminski CY, Galindo RJ, Navarrete JE et al (2023) Assessment of glycemic control by continuous glucose monitoring, hemoglobin A1c, fructosamine, and glycated albumin in patients with end-stage kidney disease and burnt-out diabetes. Diabet Care 47:267\u2013271. https:\/\/doi.org\/10.2337\/dc23-1276","journal-title":"Diabet Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02323-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:12:39Z","timestamp":1733879559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02323-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":12,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02323-z","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LM has received honoraria for speaking from Abbott, AstraZeneca, Lilly, Novo Nordisk and Sanofi. CL has received honoraria for speaking from Novo Nordisk and Lilly. Other authors have no potential conflict of interest relevant to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}